These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 27562402)
1. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome. Estrada A; Boyce AM; Brillante BA; Guthrie LC; Gafni RI; Collins MT Eur J Endocrinol; 2016 Nov; 175(5):477-483. PubMed ID: 27562402 [TBL] [Abstract][Full Text] [Related]
2. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850 [TBL] [Abstract][Full Text] [Related]
3. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. Mieszczak J; Lowe ES; Plourde P; Eugster EA J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review. Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789 [TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Management of Patients With McCune-Albright Syndrome With GH Excess and Precocious Puberty: A Case Series and Literature Review. Zhai X; Duan L; Yao Y; Xing B; Deng K; Wang L; Feng F; Liang Z; You H; Yang H; Lu L; Chen S; Wang R; Pan H; Zhu H Front Endocrinol (Lausanne); 2021; 12():672394. PubMed ID: 34777239 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty]. Xu D; Lu W; Wang X; Wang J; Xie Y; Dong Z; Wang W Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):291-296. PubMed ID: 32762164 [TBL] [Abstract][Full Text] [Related]
7. Management of precocious puberty in girls with McCune-Albright syndrome using letrozole. Wang X; Yu Q Endocr Connect; 2018 Dec; 7(12):1424-1431. PubMed ID: 30475223 [TBL] [Abstract][Full Text] [Related]
8. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome. Alves C; Silva SF J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233 [TBL] [Abstract][Full Text] [Related]
9. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review. Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532 [TBL] [Abstract][Full Text] [Related]
10. McCune-Albright syndrome (MAS): early and extensive bone fibrous dysplasia involvement and "mistaken identity" oophorectomy. Gucev Z; Tasic V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N J Pediatr Endocrinol Metab; 2010 Aug; 23(8):837-42. PubMed ID: 21073128 [TBL] [Abstract][Full Text] [Related]
11. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Girls and Boys with McCune-Albright Syndrome with Precocious Puberty - Update 2017. Neyman A; Eugster EA Pediatr Endocrinol Rev; 2017 Dec; 15(2):136-141. PubMed ID: 29292624 [TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome. Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519 [TBL] [Abstract][Full Text] [Related]
14. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study. Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760 [TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of letrozole in boys with idiopathic central precocious puberty]. Zhao X; Zhang Q Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):397-400. PubMed ID: 24750838 [TBL] [Abstract][Full Text] [Related]
16. Predictors of bone maturation, growth rate and adult height in children with central precocious puberty treated with depot leuprolide acetate. Klein KO; Dragnic S; Soliman AM; Bacher P J Pediatr Endocrinol Metab; 2018 Jun; 31(6):655-663. PubMed ID: 29750651 [TBL] [Abstract][Full Text] [Related]
17. Use of aromatase inhibitors in precocious puberty. Feuillan P; Merke D; Leschek EW; Cutler GB Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen Improves Final Height Prediction in Girls with McCune-Albright Syndrome: A Long Follow-Up. de G Buff Passone C; Kuperman H; Cabral de Menezes-Filho H; Spassapan Oliveira Esteves L; Lana Obata Giroto R; Damiani D Horm Res Paediatr; 2015; 84(3):184-9. PubMed ID: 26227563 [TBL] [Abstract][Full Text] [Related]
20. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. Feuillan PP; Jones J; Cutler GB J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]